Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Abraham B Roos, AstraZeneca R&D Gothenburg, Respiratory, Inflammation and Autoimmunity, Innovative Medicines, Pepparedsleden 1, 431 83, Mölndal, Sweden. abraham.roos@astrazeneca.com.
  • ,
  • Michiko Mori, Department of Experimental Medical Science, Lund University, Lund, Sweden.
  • ,
  • Harpreet K Gura, Institute of Clinical Medicine, Aarhus University, and Department of Respiratory Diseases and Allergy B, Aarhus University Hospital, Aarhus, Denmark.
  • ,
  • Axel Lorentz, Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • ,
  • Leif Bjermer, Department of Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
  • ,
  • Hans Jürgen Hoffmann
  • Jonas S Erjefält, Department of Experimental Medical Science, Lund University, Lund, Sweden.
  • ,
  • Martin R Stampfli, Department of Medicine, Firestone Institute of Respiratory Health at St. Joseph's Health Care, Hamilton, ON, Canada.
Original languageEnglish
Article number48
JournalRespiratory Medicine
Volume18
Number of pages4
ISSN0954-6111
DOIs
Publication statusPublished - 15 Mar 2017

    Research areas

  • Letter

See relations at Aarhus University Citationformats

ID: 111116293